Adrienne Nedved @ANNedved

Tweets

14
Followers

106
Following

165
Likes

188

John P. Leonard, MD @JohnPLeonardMD

6 months ago

#LeonardList number 1 in countdown of #ASH2025 #ASH25 top #lymphoma abstracts - Tiger et al abst 518: Use/safety peripheral vs central intravenous catheters - argues peripheral IV ok for lymphoma pts receiving anthracycline chemotherapy in most cases meetings-api.hematology.org/api/abstract/v…

John P. Leonard, MD @JohnPLeonardMD

6 months ago

Here is #LeonardList number 1 in countdown of #ASH2025 #ASH25 top #lymphoma abstracts - Tiger et al abst 518: Use/safety peripheral intravenous catheters (PIV) vs central venous catheters (CVC) for lymphoma pts receiving anthracycline chemotherapy meetings-api.hematology.org/api/abstract/v…

0 3 25 10K 10

2 8 17 3K 5

View Details

Adrienne Nedved @ANNedved

10 months ago

@RXinsider @trchealthcare Assuming this didn't happen since NatMed Pro has been having technical difficulties this week? Looking for an estimated time of return to system functioning please as I (and many colleagues) use this resource/service routinely at work. Thanks! @trchealthcare

0 0 0 13 0

View Details

Adrienne Nedved @ANNedved

2 years ago

REALBiTE with epcor and glofi in LBCL presented by Taylor Brooks, MD at @ASH24. Highlights of data courtesy of Dr. Major! Thankful to have been a part of this representing @MayoCancerCare Rochester with @YucaiWangMD

Ajay Major, MD, MBA @majorajay

2 years ago

REALBiTE RW BsAb (glofi & epco) outcomes #lymsm #ASH24: - 208 pts, 18% HGBL, 30% ECOG 2-4 - 60% prior CAR, 49% relapse w/i 90d - mPFS dismal at ~2 mos, mOS 7 mos, no diff glofi v epco - pts w/ CR did have durable responses 1/

1 3 9 4K 1

0 3 10 1K 2

View Details

Adrienne Nedved @ANNedved

2 years ago

Would love to see the inclusion of clinical oncology pharmacists not only presenting important updates as Jared is, but also part of the "Optimal Team Utilization Round Table." #PPLC24 @unmc

0 0 6 163 0

View Details

Adrienne Nedved @ANNedved

3 years ago

@KPetersonPharmD @UIPharmacy @uiowa Congratulations!!! So deserving!🥰 love the black and yellow coordination too! 💛

1 0 2 80 0

View Details

Adrienne Nedved @ANNedved

3 years ago

@KB_McCullough @AshyaBurgess_ So true!! Such a special and thoughtful gift!! 💕 We appreciate you so much too!

0 0 2 45 0

View Details

Adrienne Nedved @ANNedved

3 years ago

If you are looking for some tips on how to use and adjust patients on tafa+len therapy, then see ⤵️ for our helpful guideline! @GregNowakowski @kmaddmd #tafasitamab #lenalidomide #dlbcl

The Oncologist @OncJournal

3 years ago

This review provides a practical clinical guide for the management of patients with relapsed/refractory diffuse large B-cell #lymphoma treated with #tafasitamab + #lenalidomide in routine clinical practice. doi.org/10.1093/oncolo…

0 0 2 1K 0

0 0 4 446 0

View Details

Adrienne Nedved @ANNedved

3 years ago

@ZhuoerXie @GitaThanaMD @MayoCancerCare @GregNowakowski @CaThompsonMD @hampel_p @YucaiWangMD @YiLinMDPhD @jonaspaludo The most "Epic" gift I could think of 😆

1 0 4 156 0

View Details

Gita Thanarajasingam @GitaThanaMD

3 years ago

Celebrating the milestone birthdays of two international treasures in lymphoma! Happy birthday Toms (Witzig and Habermann)! And yes, those are “rituximab” cupcakes @MayoCancerCare #MayoLymphoma @GregNowakowski @CaThompsonMD @hampel_p @YucaiWangMD @YiLinMDPhD @jonaspaludo

5 12 61 6K 0

View Details

Gita Thanarajasingam @GitaThanaMD

4 years ago

Our esteemed newly minted Mayo MN Hematology div chair & Hodgkin lymphoma expert extraordinaire Steve Ansell presenting OS results of ECHELON-1 - practice changing for newly dx adv HL at #ASCO22 @GregNowakowski @CaThompsonMD @YucaiWangMD @UDurani @MayoCancerCare @MayoClinic @ASCO

0 5 28 0 2

View Details

Adrienne Nedved @ANNedved

4 years ago

@johnsontannerm @IDdocAdi Routinely feeling this way with our oral hem/onc drugs. 😮‍💨

0 0 1 0 0

View Details

Adrienne Nedved @ANNedved

5 years ago

@KB_McCullough @BarthRx33 @SandahlTyler Thanks @KB_McCullough! Feel free to DM me @BarthRx33.

0 0 0 0 0

View Details

Adrienne Nedved @ANNedved

5 years ago

Attempting to make my review of breast cancer for maintaining #BCOP personally more enjoyable. Kudos to my colleagues who primarily work in this complex specialty. I prefer heme any day. #twitterRX #hemoncpharm